+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
ID07383493

Study of Four Medical Devices for Treating Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis in Adults

Led by University Hospital, Clermont-Ferrand · Updated on 2026-06-15

150

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a clinical follow-up study to evaluate four medical devices named NS, NHE, NHG, and PIR. These devices are used in treating acute viral rhinitis, rhinosinusitis, and rhinopharyngitis. The study aims to collect real-life clinical data to confirm the tolerance, safety, and effectiveness of these treatments and to assess their benefit-to-risk ratio. Participants are randomly assigned to one of four groups, each receiving one of the medical devices PIR, NS, NHE, or NHG. The study does not mask the treatment assignment and follows a parallel design. Participants will use the assigned device during the study period, with outcomes measured from day 1 through day 15. During the study, participants will undergo assessments at the start day 1 and follow-up day 15 visits. Researchers will monitor tolerance, effectiveness, quality of life impact, and any device defects throughout this period. The total study participation spans approximately two weeks, during which clinical data will be collected to evaluate the treatment experience and safety.

CONDITIONS

Brief Title

RhinAV_Evaluation of Treatments for Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis

Research Team

L

Lise Laclautre

L

Lise Laclautre

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here